BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 27, 2017
View Archived Issues
Biocon launches bevacizumab biosimilar Krabeva in India
Read More
Plasmepsins IX and X as promising new dual targets for malaria eradication
Read More
Data show encouraging activity with BMS-986205 plus nivolumab in phase I/II study
Read More
Researchers describe novel potent peptidic inhibitors of influenza hemagglutinin
Read More
Chemo group changes its name to Insud Pharma
Read More
Novel IDO-1 inhibitors discovered at GlaxoSmithKline
Read More
University of Minnesota patents new monocarboxylate transporter 1/4 inhibitors
Read More
Inflection Biosciences and RCSI collaborate to understand mechanisms of resistance in breast cancer
Read More
University of Michigan presents histone-lysine N-methyltransferase ASH1L inhibitors
Read More
Vanc set to launch INSTI HIV rapid point-of-care test
Read More
MA-0217 as a promising new agent for ischemic acute kidney injury
Read More
Novel antiparasitic compounds synthesized at Anacor
Read More
Jubilant Biosys describes new dual KDM1A/HDAC inhibitors
Read More
Pharming submits sBLA for Ruconest for prevention of HAE attacks
Read More
AstraZeneca seeks Japanese approval for Tagrisso in first-line EGFR-mutated NSCLC
Read More
Genfit contributes to LITMUS European consortium in NAFLD
Read More
AstraZeneca and Chinese FIIF to establish joint venture in China
Read More
Phase III study finds significant ON time improvement with sublingual apomorphine film
Read More
Immungenetics initiates DrainAD phase II study of thiethylperazine for the treatment of AD
Read More
VS-605, a novel highly effective phosphate binder
Read More
HitGen and Boehringer Ingelheim establish drug discovery research collaboration
Read More
Symphogen opens phase I study of Sym-021 in advanced solid tumor malignancies or lymphomas
Read More
Phase II results for nesvacumab and aflibercept combination therapy do not warrant progression
Read More
New study explores BOLT with BMT in primary immunodeficiency patients with end-stage lung disease
Read More
Merck Sharp & Dohme initiates phase I study of MK-7252 in healthy subjects
Read More
Japanese approval sought for DE-117 for glaucoma and ocular hypertension
Read More
